Opto Circuits' Group Company receives U.S. FDA clearance

20 Feb 2014 Evaluate

Cardiac Science Corporation, a group company of Opto Circuits (India) has received 510(k) Market clearance for the Powerheart G5 AED from U.S. FDA (Food and Drug Administration), allowing the company to begin selling the AED later this year along with its successful Powerheart G3 product line.

The Powerheart family of AEDs is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered sudden cardiac arrest (SCA), a condition in which the heart suddenly stops beating due to irregularities in its electrical system. The condition strikes as many as 360,000 Americans annually with the majority of cases being fatal, according to the American Heart Association.

However, the American Heart Association notes that at least 20,000 lives could be saved annually by prompt use of AEDs. Ultimately, with broad deployment of AEDs among trained responders, as many as 50,000 deaths due to SCA could be prevented each year-a cause Cardiac Science is firmly behind.

The Powerheart G5 will be available for purchase in the United States later this year.

Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.

 

Opto Circuits (I) Share Price

1.78 0.00 (0.00%)
23-May-2022 18:01 View Price Chart
Peers
Company Name CMP
Poly Medicure 1899.60
Laxmi Denta 269.50
Nureca Ltd. 305.20
Hemant Surgical Inds 294.60
Prevest Denpro 438.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×